HOME > ARTICLES
Our portfolio company GYANT has been selected as one of the six startups by the Mayo Clinic, the top US hospital, and Arizona State University, the number 1 university for innovation in the country, for their inaugural MedTech Accelerator cohort.
Our portfolio company, LYRIC, raised 160 M$ in debt and equity. Airbnb led the equity financing, along with Tishman Speyer, RXR Realty, Obvious Ventures, NEA and Tusk Ventures.
Our portfolio company, ALTOIDA, which provides a digital platform using artificial intelligence and machine learning to help predict Alzheimer’s disease, announced the close of a $6.3 million round of venture capital financing.
Our portfolio company, THE GLUE, enters a new partnership with Belfius bank, the second largest bank and insurer in Belgium with more than 3.5 million customers.
Our portfolio company, QWIL, has been featured by “Fast Company”, the American business magazine, as one of the 10 Most Innovative Fintech Companies in 2019, alongside with successful Square Inc, Acorns…
At the Mobile World Congress 2019 in Barcelona, our portfolio company, ONEVISAGE, announces a partnership with Orbbec, the leading 3D software authentication company.
Our portfolio company LUNAPHORE announces that its first product, LabSatTM for research applications, is now released for commercialization.
ONEVISAGE, the inventor of 3D facial biometry and 3D graphical authentication running on standard mobile devices, and globaliD, a leading digital identity service provider, announced today a partnership to integrate ONEVISAGE’s Premier Face™ 3D facial biometry technology in globaliD’s digital identity offering.
Our portfolio company NEZASA, leading Swiss travel tech start-up, closed a Series A investment of CHF 2.5 million CHF, led by Credit Suisse. Additional funds come from existing shareholders, such as Howzat Partners, ALPANA VENTURES, Reinhart Capital and Investiere.ch.
Congratulations to our portfolio company LUNAPHORE which brought back the Swiss Technology Award 2018 in the “Startup” category from the Swiss Innovation Forum SIF18!
Our portfolio company AVA further expands in Asia and introduces one-Year “Pregnancy Guarantee”
Check the logo
Series A financing round of CHF 6 million with Alpana Ventures and angels
Alzheimer’s disease prediction is “EIT innovation award winner 2018”
Our portfolio company BEEKEEPER has secured $13 million in funding during their Series A extension round. SamsungNext, the electronics giant’s venture capital business also joined the funding round, while Alpana Ventures was proud to continue its support.
Lunaphore closes a CHF 5.3M Series B financing round
More than 1’000 babies born to users of AVA’s fertility tracking
FOLLOW ALPANA NEWS:
SWITZERLAND
Tour de l’Ile 1
CH – 1204 Geneva
+41 22 312 20 50
Copyright 2021 by ALPANA VENTURES – Disclaimer